Assessing the cost-effectiveness of immunomodulatory therapies for relapsing-remitting multiple sclerosis based on long-term data

Bell, C., Graham, J., Earnshaw, S., Oleen-Burkey, M., Castelli-Haley, J., & Johnson, KP. (2006). Assessing the cost-effectiveness of immunomodulatory therapies for relapsing-remitting multiple sclerosis based on long-term data. Value in Health, 9(3), A81-A82.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Consuming illicit opioids during a drug overdose epidemic
Article

Cost, reach, and representativeness of recruitment efforts for an online skin cancer risk reduction intervention trial for young adults
Article

News coverage about aspirin as a countervailing force against low-dose aspirin campaign promotion